ArticleTransplant infectious disease : an official journal of the Transplantation Society2021

Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib.

Francesco Saraceni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.